Zoloft® Birth Defects Spur Investigations
Zoloft® Birth Defects Spur Investigations The U.S. Food and Drug Administration (FDA) Links SSRI Antidepressants to Birth Defect. (PRWEB) July 27, 2011 Since the FDA notified healthcare professionals and patients of a possible link between Zoloft® (sertraline Hcl) and a congenital defect, claims against Pfizer Inc. have been on the rise. RodaNast , P.C., a litigation firm is sponsoring ZoloftBirthDefectLawyer.com, an online resource that was designed to provide useful information about the birth defects associated with Zoloft® when taken during pregnancy. According to Roda
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4